Therefore, small-molecule inhibitors of palmitoyl-acyltransferase ZDHHC7 or directly targeting NLRP3 Cys126 residue can potentially suppress inflammasome activation and thus may be useful for treating inflammation and autoimmune diseases. Here, ZDHHC7 is linked to autoimmune disease.